Drugs / DC-Cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05461235 | Jul 2022 → Jul 2025 | digestive system cancer | China Medical University, China | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DC-Cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05461235 ↗ |